Trial Details
AuthorisedBasic Information
| Clinical ID | c5055 |
|---|---|
| Identifier | EUCTR2022-002648-35-NL |
| Trial Title | Prospective Analysis of Pharmacokinetic Infliximab Data in pediatric CD_x000D_patients - PRO-RAPID |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn's disease;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Interventions | Product Name: InfliximabPharmaceutical Form: Powder for concentrate for solution for infusion |
Participant Information
| Sponsor | Erasmus Medical Center |
|---|---|
| City | NULL |
| Country/Region | Netherlands;Italy |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |